Source: iQoncept / Shutterstock
Chromocell Therapeutics (NYSEMKT:CHRO) just reported results for the first quarter of 2024.
- Chromocell Therapeutics reported earnings per share of -55 cents.
- The company did not report any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/chro-stock-earnings-chromocell-therapeutics-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC